Iradimed corporation (IRMD)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Revenue

8,677

10,890

9,963

9,225

8,437

8,339

7,614

7,376

7,108

6,704

5,689

5,524

5,162

5,990

7,673

9,868

8,964

8,799

8,193

7,609

6,991

3,583

3,811

4,700

3,557

2,479

2,775

Cost of revenue

2,213

2,741

2,168

1,858

2,047

1,982

1,826

1,710

1,691

1,640

1,307

1,234

1,387

1,304

1,405

1,739

1,705

1,499

1,590

1,422

1,328

918

959

869

656

669

767

Gross profit

6,463

8,148

7,795

7,367

6,389

6,356

5,787

5,665

5,416

5,064

4,381

4,290

3,774

4,686

6,267

8,129

7,258

7,299

6,603

6,187

5,663

2,664

2,852

3,830

2,900

1,809

2,007

Operating expenses:
General and administrative

2,862

2,968

2,609

2,460

2,412

2,147

2,181

2,078

2,303

2,152

2,551

2,189

2,107

1,577

1,869

3,088

2,259

2,140

1,675

1,985

1,968

1,331

1,261

1,130

1,092

640

527

Sales and marketing

2,433

2,562

2,297

2,199

2,110

2,049

1,784

1,516

1,645

1,562

1,251

1,323

1,364

1,238

1,346

1,409

1,283

1,306

1,206

1,104

1,088

792

880

864

759

513

495

Research and development

430

379

369

331

352

367

373

395

379

349

382

449

541

364

457

291

234

499

518

403

342

315

303

225

224

299

204

Total operating expenses

5,726

5,909

5,276

4,991

4,875

4,564

4,339

3,990

4,329

4,064

4,185

3,962

4,013

3,180

3,673

4,789

3,777

3,947

3,400

3,493

3,399

2,439

2,446

2,220

2,076

1,454

1,227

Income from operations

737

2,238

2,518

2,375

1,513

1,792

1,448

1,675

1,087

999

196

327

-238

1,505

2,593

3,340

3,481

3,352

3,202

2,693

2,264

225

406

1,610

824

355

779

Other income, net

98

115

110

78

92

83

42

27

40

32

28

21

29

9

-4

-4

31

-36

64

46

46

-54

-8

11

3

18

22

Income before provision for income taxes

835

2,354

2,628

2,453

1,606

1,875

1,490

1,703

1,127

1,031

224

348

-208

1,514

2,589

3,335

3,513

3,315

3,267

2,739

2,311

170

397

1,621

827

374

802

Provision for income tax benefit

-933

-887

174

364

-239

168

-909

348

286

848

32

-8

24

374

1,029

1,104

1,231

911

1,400

969

823

-100

160

602

304

113

244

Net income

1,769

3,241

2,454

2,088

1,845

1,707

2,400

1,354

841

183

192

357

-233

1,140

1,560

2,231

2,282

2,404

1,867

1,770

1,487

270

237

1,018

523

260

558

Change in fair value of available-for-sale securities, net of tax (benefit) expense of $(6,369) and $70 for the three months ended September 30, 2015 and 2014, respectively, and $(8,833) and $(2,681) for nine months ended September 30, 2015 and 2014, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

2

-0

-4

Realized gain on available-for-sale securities reclassified to net income, net of tax of $70 and $2,560 for the three and nine months ended September 30, 2014, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Comprehensive income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

237

1,020

525

259

553

Net income per share:
Basic (in dollars per share)

0.15

0.27

0.22

0.19

0.17

0.16

0.22

0.13

0.08

0.02

0.02

0.03

-0.02

0.10

0.15

0.21

0.21

0.21

0.17

0.16

0.14

-0.01

0.02

0.15

0.07

0.04

0.08

Diluted (in dollars per share)

0.14

0.26

0.20

0.17

0.15

0.14

0.20

0.11

0.07

0.01

0.02

0.03

-0.02

0.09

0.13

0.19

0.19

0.18

0.15

0.15

0.12

0.01

0.02

0.11

0.06

0.03

0.07

Weighted average shares outstanding:
Basic (in shares)

11,891

11,566

11,369

11,163

11,029

10,950

10,824

10,651

10,608

10,561

10,565

10,687

10,740

10,714

10,684

10,778

11,095

11,103

11,028

10,974

10,906

10,861

10,112

7,000

7,000

7,000

7,000

Diluted (in shares)

12,365

12,341

12,309

12,226

12,227

12,353

12,195

12,011

11,879

12,769

11,643

11,727

10,740

11,798

11,867

11,966

12,326

13,759

12,382

12,107

11,977

11,870

11,269

8,878

8,859

8,665

8,495